Microwave Ablation Clinical Trial
Official title:
Microwave Ablation Versus Radiofrequency Ablation for the Treatment of Severe Complicated Monochorionic Pregnancies in the Peking University Third Hospital : A Pilot Randomised Controlled Trial
Complicated pregnancies refer some special complications, including twin to twin transfusion
syndrome(TTTS), twin reverse arterial perfusion(TRAP), selective intrauterine fetal growth
restriction(sIUGR), twin anemia-polycythemia sequence(TAPS), one fetal death or structural
abnormalities, etc. Complicated twins are often associated with high perinatal morbidity and
mortality. Severe complicated twins can be treated with fetal-reduction surgery during
pregnancy, which can improve the survival rate of retained fetuses and reduce the disability
rate. The managements include mechanical umbilical cord ligation or thermal coagulation
obliteration, such as bipolar coagulation (BCC), radiofrequency ablation (RFA), and laser
coagulation.Nowadays radiofrequency ablation reduction is the most common, which processes a
higher survival rate and fewer maternal and fetal complications compared with other
ways.Latest experience suggests that microwave ablation(MWA) is also easy to be used and the
therapeutic effect is similar with RFA, but there is no convincing evidence. Compared with
radiofrequency ablation, MWA has the advantages of simple operation and time, and avoids the
problems of tissue carbonization, drying and heat sink effect. For fetation reduction
surgery, the main advantage is that the endothermic effect near the blood vessels is smaller,
which enables microwave fetation reduction to have a larger ablation range and a higher
thermal effect. This study is comparing Microwave Ablation(MWA) and radiofrequency ablation
(RFA) methods for selective fetal reduction in the treatment of complicated monochorionic
(MC) multifetal gestations.
This is a pilot randomised controlled trial(RCT) of 60 patients who undergo selective fetal
reduction. The subjects of this study were all pregnant women and their offspring who
underwent reduction surgery in the third hospital of Beijing University, and patients are
randomly assigned 1:1 to different intervention groups by parallel design. The outcome
evaluators were blind. Collecting their surgery, clinical information and maternal and fetal
complications at a week and a month after surgery, 42 days and 6 months after delivery, to
verify the safety and efficacy of MWA, and find a better treatment plan for complicated
monochorionic pregnancies .The primary outcome was neonatal survival rate.
Medical charts were reviewed for the details of surgery and the pregnancy outcomes if the patient delivered at the authors'institution. In the event of delivery at distant locations, patients were contacted by telephone to obtain delivery and neonatal information. Patients are randomly assigned 1:1 to different intervention groups by parallel design. Chorionicity was assessed by the referring physicians during the first trimester. All patients underwent comprehensive ultrasound examination to confirm the fetal diagnosis, chorionicity, amnionicity and cervical length upon arrival at Peking University Third Hospital. Monochorionicity was confirmed through the ultrasound findings of a single placenta, a thin intervening membrane, lack of a lambda sign and concordance for fetal gender. Patients were counseled about the risks and benefits of expectant management vs. selective reduction. Written informed consent was obtained. Statistical analysis was performed using the statistical software Statistical Product and Service Solutions(SPSS), for comparison of entry and outcome variables using the chi-square test, Fisher's exact test and the Student's t-test, where appropriate. P < 0.05 was considered as statistically significant. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04626986 -
Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor
|
N/A | |
Completed |
NCT05068076 -
Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC
|
N/A | |
Not yet recruiting |
NCT03490890 -
Microwave Ablation in Ground Glass Nodules
|
Phase 2 | |
Completed |
NCT06031129 -
Butorphanol in Pain Following Ablation for Hepatic Tumor
|
N/A | |
Recruiting |
NCT03082378 -
Central Obesity and Hepatocellular Carcinoma
|
N/A | |
Recruiting |
NCT03609268 -
Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma
|
N/A | |
Recruiting |
NCT03963726 -
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer.
|
N/A | |
Recruiting |
NCT05361538 -
Study of Microwave Spherical Ablation and Traditional Microwave Ablation in Single Hepatocellular Carcinoma ≤5cm
|
N/A | |
Recruiting |
NCT05444478 -
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
|
N/A | |
Recruiting |
NCT05990257 -
CMRA for US-guided-MWA of Liver Tumors
|
N/A | |
Recruiting |
NCT03286413 -
Comparison of Microwave Ablation With Cryoablation for Breast Tumor
|
N/A | |
Recruiting |
NCT03277716 -
Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge
|
N/A | |
Terminated |
NCT04803890 -
"No-Touch" Radiofrequency Ablation for Small Hepatocellular Carcinoma (≤ 3cm): A Prospective Multicenter Study
|
N/A |